Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

NCT05687136 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

66

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Peposertib
PROCEDURE: Positron Emission Tomography
DRUG: Tuvusertib

Sponsor

National Cancer Institute (NCI)